Datametrex Receives $1M Order from Fortune 500 Client
Rhea-AI Summary
Datametrex (OTC:DTMXF) received a Purchase Order of approximately $1,000,000 from a Fortune 500 conglomerate headquartered in South Korea on February 18, 2026. The order is for Nutanix-based hyperconverged infrastructure software licenses and carries an estimated profit margin of ~53%.
This P.O. validates Datametrex's data centre operations and supports its land-and-expand strategy, managed services platform, and efforts to build a predictable, recurring revenue base via Datametrex Korea.
Positive
- $1,000,000 purchase order received
- Estimated ~53% profit margin on the order
- Validation of HCI data centre operations and scalability
- Supports land-and-expand strategy and recurring revenue build
Negative
- Single $1,000,000 P.O.; no disclosed multi-year contract
- No delivery schedule or recurring billing terms disclosed
News Market Reaction
On the day this news was published, DTMXF gained 7.75%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
TORONTO, ON / ACCESS Newswire / February 18, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the receipt of a Purchase Order ("P.O.") from a large Fortune 500 company headquartered in South Korea, with offices across Asia and diversified business interests including consumer retail and other sectors. This validates the performance, scalability, and reliability of its data centre operations and infrastructure solutions.
The order totals approximately
Paul Haber, CEO of Datametrex, commented, "Receiving this P.O. from the Fortune 500 global conglomerate represents an important milestone in demonstrating the reliability and scalability of our HCI-based data centre operations and managed services platform. The receipt of this P.O. underscores the strength of our customer relationships and the value proposition of our solutions, while supporting the development of a predictable and recurring revenue base. We remain focused on disciplined execution, operational excellence, and the strategic expansion of our AI-enabled and technology-driven infrastructure services globally through Datametrex Korea".
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our website at www.datametrex.com.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
###
SOURCE: Datametrex AI Limited
View the original press release on ACCESS Newswire